- Home
- CDW vs RGC Comparison
CDW vs RGC Comparison
Compare CDW & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDW | RGC |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 13.2B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CDW | RGC |
|---|---|---|
| Price | $122.34 | $25.82 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $164.88 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 135.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 8.08 | N/A |
| Revenue | ★ $10,768,600,000.00 | N/A |
| Revenue This Year | $3.87 | N/A |
| Revenue Next Year | $4.04 | N/A |
| P/E Ratio | $15.36 | ★ N/A |
| Revenue Growth | ★ 6.32 | N/A |
| 52 Week Low | $119.83 | $3.99 |
| 52 Week High | $189.45 | $950.00 |
Technical Indicators
Market Signals| Indicator | CDW | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 46.27 |
| Support Level | $121.46 | $24.31 |
| Resistance Level | $136.09 | $26.42 |
| Average True Range (ATR) | 5.19 | 2.52 |
| MACD | -0.70 | -0.48 |
| Stochastic Oscillator | 14.80 | 8.68 |
Price Performance
Historical ComparisonAbout CDW CDW Corporation
CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.